What is CIDP? Section Bibliography

• Chio A, Plano F, Vercellino M, et al. Epidemiology of CIDP in Italy: a collaborative study. Abstract, 12th meeting of the European Neurological Society, 2002.
• Dalakas MC, Engel WK: Chronic relapsing dysimmune polyneuropathy: pathogenesis and treatment.  Ann Neurol 1991;(Suppl.):134-145.
• Dalakas MC, Teravainen H, Engel WK: Tremor as a feature of chronic relapsing and dysgammaglobulinemic neuropathies. Incidence and management. Arch Neurol 1984;41:711-714.
• Dalakas MC. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. Curr Opin Neurol 1999;12:403-409.
• Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin. Proc. 1975; 50(11):621-637.
• Latov N. Diagnosis of CIDP. Neurology 2002;59 (12 suppl 6):S2-6.
• Lunn MPT, Manji H, Choudhary PP, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurology Neurosurgery and Psychiatry 1999; 66(5):677-680.
• McLeod JG, Pollard JD, Macaskill P, et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46(6)910-913.
• Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001;56:445-449.
• Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur. J Neurol 2001;8(2):157-165.
• Van Dijk GW, Notermans NC, Frassen H, Wokke JH. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study. J Neurol 1999;246:1134-1139.